Omnicell, Inc. (OMCL)
USD 44.18
(-2.28%)
USD 44.18
(-2.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.22 Billion USD | 0.73% |
| 2022 | 2.21 Billion USD | 3.19% |
| 2021 | 2.14 Billion USD | 17.43% |
| 2020 | 1.82 Billion USD | 47.04% |
| 2019 | 1.24 Billion USD | 14.76% |
| 2018 | 1.08 Billion USD | 10.3% |
| 2017 | 980.3 Million USD | 4.83% |
| 2016 | 935.1 Million USD | 61.57% |
| 2015 | 578.74 Million USD | 3.31% |
| 2014 | 560.21 Million USD | 13.75% |
| 2013 | 492.5 Million USD | 10.99% |
| 2012 | 443.73 Million USD | 22.59% |
| 2011 | 361.96 Million USD | 5.44% |
| 2010 | 343.3 Million USD | 6.84% |
| 2009 | 321.33 Million USD | 3.96% |
| 2008 | 309.09 Million USD | -5.89% |
| 2007 | 328.42 Million USD | 112.39% |
| 2006 | 154.63 Million USD | 53.97% |
| 2005 | 100.42 Million USD | 0.94% |
| 2004 | 99.49 Million USD | 17.79% |
| 2003 | 84.46 Million USD | 28.87% |
| 2002 | 65.54 Million USD | -9.11% |
| 2001 | 72.11 Million USD | 64.25% |
| 2000 | 43.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.28 Billion USD | 2.55% |
| 2024 Q3 | 2.3 Billion USD | 0.52% |
| 2024 Q2 | 2.29 Billion USD | 0.35% |
| 2023 Q2 | 2.19 Billion USD | -2.53% |
| 2023 Q1 | 2.25 Billion USD | 1.81% |
| 2023 Q4 | 2.22 Billion USD | 0.24% |
| 2023 Q3 | 2.22 Billion USD | 1.26% |
| 2023 FY | 2.22 Billion USD | 0.73% |
| 2022 Q2 | 2.13 Billion USD | 0.42% |
| 2022 Q1 | 2.12 Billion USD | -0.93% |
| 2022 Q3 | 2.17 Billion USD | 2.26% |
| 2022 Q4 | 2.21 Billion USD | 1.43% |
| 2022 FY | 2.21 Billion USD | 3.19% |
| 2021 FY | 2.14 Billion USD | 17.43% |
| 2021 Q1 | 1.88 Billion USD | 3.4% |
| 2021 Q2 | 1.96 Billion USD | 3.94% |
| 2021 Q3 | 2.05 Billion USD | 4.61% |
| 2021 Q4 | 2.14 Billion USD | 4.44% |
| 2020 FY | 1.82 Billion USD | 47.04% |
| 2020 Q1 | 1.23 Billion USD | -0.74% |
| 2020 Q2 | 1.22 Billion USD | -0.75% |
| 2020 Q3 | 1.71 Billion USD | 40.64% |
| 2020 Q4 | 1.82 Billion USD | 6.12% |
| 2019 Q1 | 1.17 Billion USD | 8.86% |
| 2019 FY | 1.24 Billion USD | 14.76% |
| 2019 Q2 | 1.19 Billion USD | 1.69% |
| 2019 Q3 | 1.24 Billion USD | 3.95% |
| 2019 Q4 | 1.24 Billion USD | -0.28% |
| 2018 FY | 1.08 Billion USD | 10.3% |
| 2018 Q4 | 1.08 Billion USD | 2.74% |
| 2018 Q3 | 1.05 Billion USD | 2.52% |
| 2018 Q2 | 1.02 Billion USD | -1.39% |
| 2018 Q1 | 1.04 Billion USD | 6.19% |
| 2017 Q3 | 923.81 Million USD | 1.53% |
| 2017 Q4 | 980.3 Million USD | 6.11% |
| 2017 FY | 980.3 Million USD | 4.83% |
| 2017 Q1 | 909.76 Million USD | -2.71% |
| 2017 Q2 | 909.9 Million USD | 0.02% |
| 2016 Q1 | 923.77 Million USD | 59.62% |
| 2016 Q3 | 931.41 Million USD | 1.97% |
| 2016 FY | 935.1 Million USD | 61.57% |
| 2016 Q2 | 913.42 Million USD | -1.12% |
| 2016 Q4 | 935.1 Million USD | 0.4% |
| 2015 Q2 | 601.02 Million USD | 5.27% |
| 2015 Q3 | 576.72 Million USD | -4.04% |
| 2015 Q1 | 570.92 Million USD | 1.91% |
| 2015 Q4 | 578.74 Million USD | 0.35% |
| 2015 FY | 578.74 Million USD | 3.31% |
| 2014 Q1 | 510.4 Million USD | 3.64% |
| 2014 FY | 560.21 Million USD | 13.75% |
| 2014 Q3 | 547.31 Million USD | 1.87% |
| 2014 Q4 | 560.21 Million USD | 2.36% |
| 2014 Q2 | 537.25 Million USD | 5.26% |
| 2013 Q3 | 505.16 Million USD | 7.0% |
| 2013 Q1 | 457.35 Million USD | 3.07% |
| 2013 FY | 492.5 Million USD | 10.99% |
| 2013 Q4 | 492.5 Million USD | -2.51% |
| 2013 Q2 | 472.12 Million USD | 3.23% |
| 2012 Q4 | 443.73 Million USD | 5.15% |
| 2012 Q2 | 416.25 Million USD | 11.32% |
| 2012 Q1 | 373.92 Million USD | 3.3% |
| 2012 FY | 443.73 Million USD | 22.59% |
| 2012 Q3 | 422 Million USD | 1.38% |
| 2011 FY | 361.96 Million USD | 5.44% |
| 2011 Q4 | 361.96 Million USD | 0.96% |
| 2011 Q3 | 358.51 Million USD | 2.59% |
| 2011 Q2 | 349.45 Million USD | 1.17% |
| 2011 Q1 | 345.41 Million USD | 0.64% |
| 2010 FY | 343.3 Million USD | 6.84% |
| 2010 Q2 | 333.49 Million USD | 0.54% |
| 2010 Q3 | 339.73 Million USD | 1.87% |
| 2010 Q4 | 343.22 Million USD | 1.03% |
| 2010 Q1 | 331.69 Million USD | 2.93% |
| 2009 Q1 | 307.11 Million USD | -0.46% |
| 2009 FY | 321.33 Million USD | 3.96% |
| 2009 Q2 | 314.6 Million USD | 2.44% |
| 2009 Q3 | 323.03 Million USD | 2.68% |
| 2009 Q4 | 322.26 Million USD | -0.24% |
| 2008 Q3 | 293.51 Million USD | 3.32% |
| 2008 FY | 309.09 Million USD | -5.89% |
| 2008 Q1 | 307.72 Million USD | -6.3% |
| 2008 Q2 | 284.06 Million USD | -7.69% |
| 2008 Q4 | 308.54 Million USD | 5.12% |
| 2007 Q1 | 157.92 Million USD | 2.13% |
| 2007 Q4 | 328.42 Million USD | 11.36% |
| 2007 Q3 | 294.91 Million USD | 6.21% |
| 2007 Q2 | 277.67 Million USD | 75.83% |
| 2007 FY | 328.42 Million USD | 112.39% |
| 2006 Q4 | 154.63 Million USD | 11.64% |
| 2006 Q3 | 138.5 Million USD | 12.83% |
| 2006 Q2 | 122.75 Million USD | 14.93% |
| 2006 FY | 154.63 Million USD | 53.97% |
| 2006 Q1 | 106.8 Million USD | 6.34% |
| 2005 FY | 100.42 Million USD | 0.94% |
| 2005 Q1 | 94.78 Million USD | -4.73% |
| 2005 Q2 | 94.59 Million USD | -0.21% |
| 2005 Q3 | 103.65 Million USD | 9.58% |
| 2005 Q4 | 100.42 Million USD | -3.11% |
| 2004 Q4 | 99.49 Million USD | 0.8% |
| 2004 Q3 | 98.7 Million USD | 3.84% |
| 2004 FY | 99.49 Million USD | 17.79% |
| 2004 Q2 | 95.05 Million USD | 4.39% |
| 2004 Q1 | 91.05 Million USD | 7.8% |
| 2003 Q2 | 65.01 Million USD | 5.86% |
| 2003 Q3 | 71.14 Million USD | 9.43% |
| 2003 Q4 | 84.46 Million USD | 18.72% |
| 2003 FY | 84.46 Million USD | 28.87% |
| 2003 Q1 | 61.41 Million USD | -6.29% |
| 2002 Q3 | 70.12 Million USD | 0.95% |
| 2002 FY | 65.54 Million USD | -9.11% |
| 2002 Q2 | 69.46 Million USD | 2.24% |
| 2002 Q1 | 67.94 Million USD | -5.78% |
| 2002 Q4 | 65.54 Million USD | -6.54% |
| 2001 FY | 72.11 Million USD | 64.25% |
| 2001 Q4 | 72.11 Million USD | 2.54% |
| 2001 Q3 | 70.33 Million USD | 48.21% |
| 2001 Q2 | 47.45 Million USD | 0.88% |
| 2001 Q1 | 47.03 Million USD | 0.0% |
| 2000 FY | 43.9 Million USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 1.97 Billion USD | -12.959% |
| GE HealthCare Technologies Inc. | 32.45 Billion USD | 93.138% |
| Sharecare, Inc. | 613.63 Million USD | -262.9% |
| Progyny, Inc. | 756.62 Million USD | -194.319% |
| Aclarion, Inc. | 2.45 Million USD | -90431.813% |
| CareMax, Inc. | 623.3 Million USD | -257.272% |
| Simulations Plus, Inc. | 196.63 Million USD | -1032.47% |
| CareCloud, Inc. | 79.51 Million USD | -2700.611% |
| Forian Inc. | 59.37 Million USD | -3650.457% |
| Bullfrog AI Holdings, Inc. Warrants | 2.77 Million USD | -80102.018% |
| Bullfrog AI Holdings, Inc. Common Stock | 2.77 Million USD | -80102.018% |
| Minerva Surgical, Inc. | 68.9 Million USD | -3132.044% |
| Definitive Healthcare Corp. | 1.82 Billion USD | -21.961% |
| Zhongchao Inc. | 24.41 Million USD | -9020.328% |
| Accolade, Inc. | 788.15 Million USD | -182.545% |
| Streamline Health Solutions, Inc. | 41.74 Million USD | -5235.117% |
| Ontrak, Inc. | 19.84 Million USD | -11120.79% |
| SOPHiA GENETICS SA | 206.15 Million USD | -980.191% |
| R1 RCM Inc. | 4.96 Billion USD | 55.105% |
| Spok Holdings, Inc. | 227.68 Million USD | -878.056% |
| Privia Health Group, Inc. | 999.9 Million USD | -122.71% |
| EUDA Health Holdings Limited | 1.31 Million USD | -169824.793% |
| HeartBeam, Inc. | 17.13 Million USD | -12899.113% |
| GeneDx Holdings Corp. | 473.67 Million USD | -370.129% |
| TruBridge, Inc. | 434.42 Million USD | -412.607% |
| Nutex Health, Inc. | 398.24 Million USD | -459.172% |
| Renalytix Plc | 7.97 Million USD | -27833.743% |
| Sharecare, Inc. | 613.63 Million USD | -262.9% |
| Health Catalyst, Inc. | 701.81 Million USD | -217.303% |
| 10x Genomics, Inc. | 965.14 Million USD | -130.73% |
| GoodRx Holdings, Inc. | 1.58 Billion USD | -40.161% |
| SCWorx Corp. | 6.27 Million USD | -35369.923% |
| Schrödinger, Inc. | 802.95 Million USD | -177.335% |
| HealthEquity, Inc. | 3.23 Billion USD | 31.195% |
| HealthStream, Inc. | 499.94 Million USD | -345.427% |
| MSP Recovery, Inc. | 3.15 Billion USD | 29.529% |
| Augmedix, Inc. | 66.71 Million USD | -3238.047% |
| BrightSpring Health Services, Inc. Common Stock | 5.79 Billion USD | 61.543% |
| Ontrak, Inc. | 19.84 Million USD | -11120.79% |
| SHL Telemedicine Ltd. | 113.04 Million USD | -1869.823% |
| CareCloud, Inc. | 79.51 Million USD | -2700.611% |
| Premier, Inc. | 3.42 Billion USD | 35.05% |
| Certara, Inc. | 1.56 Billion USD | -42.462% |
| GeneDx Holdings Corp. | 473.67 Million USD | -370.129% |
| OneMedNet Corporation | 463.05 Thousand USD | -480807.966% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.79 Billion USD | 61.543% |
| EUDA Health Holdings Limited | 1.31 Million USD | -169824.793% |
| HeartBeam, Inc. | 17.13 Million USD | -12899.113% |
| CareCloud, Inc. | 79.51 Million USD | -2700.611% |
| Mangoceuticals, Inc. | 1.05 Million USD | -211823.566% |
| CareMax, Inc. | 623.3 Million USD | -257.272% |
| Healthcare Triangle, Inc. | 10.04 Million USD | -22060.195% |
| National Research Corporation | 122.43 Million USD | -1718.795% |
| Aclarion, Inc. | 2.45 Million USD | -90431.813% |
| OptimizeRx Corporation | 183.37 Million USD | -1114.392% |